Scientific Reports · 2017 · 32 citations · 43 references
MedicineImmunologyOphthalmologyImmunopathologyInflammationOcular ImmunologyCorneal ImmunologyDry Eye DiseaseImmunopathology Of The EyeInflammatory SignalingOcular Cytokine BiologyOcular InflammationDry Eye Disease ImmunopathogenesisDry Eye ImmunopathologyDry Eye InflammationMicrospheresPeripheral Regulatory T CellsPro-inflammatory Cytokine ExpressionT Cell-mediated Ocular InflammationT-cell Mediated Ocular Inflammation
Dry eye disease (DED) is a highly prevalent, ocular disorder characterized by an abnormal tear film and ocular surface. Recent experimental data has suggested that the underlying pathology of DED involves inflammation of the lacrimal functional unit (LFU), comprising the cornea, conjunctiva, lacrimal gland and interconnecting innervation. This inflammation of the LFU ultimately results in tissue deterioration and the symptoms of DED. Moreover, an increase of pathogenic lymphocyte infiltration and the secretion of pro-inflammatory cytokines are involved in the propagation of DED-associated inflammation. Studies have demonstrated that the adoptive transfer of regulatory T cells (Tregs) can mediate the inflammation caused by pathogenic lymphocytes. Thus, as an approach to treating the inflammation associated with DED, we hypothesized that it was possible to enrich the body's own endogenous Tregs by locally delivering a specific combination of Treg inducing factors through degradable polymer microspheres (TRI microspheres; TGF-β1, Rapamycin (Rapa), and IL-2). This local controlled release system is capable of shifting the balance of Treg/T effectors and, in turn, preventing key signs of dry eye disease such as aqueous tear secretion, conjunctival goblet cells, epithelial corneal integrity, and reduce the pro-inflammatory cytokine milieu in the tissue.
43
Immunological Reviews · 2011 · 754 citations
Betulin Is a Potent Anti-Tumor Agent that Is Enhanced by Cholesterol
Franziska B. Mullauer, Jan H. Kessler, Jan Paul Medema · PLoS ONE · 2009 · 695 citations · Full text
Medicine, Oncology, Pharmacology +14
Geoffrey L. Stephens, Rebecca S. McHugh, Matthew J. Whitters et al. · The Journal of Immunology · 2004 · 500 citations